LGT Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

LGT Fund Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$283K	Sell	4,672 -3,172	-40%	-$185K	0.01%	230
2025 Q4	$425K	Hold	7,844	–	–	0.03%	183
2025 Q3	$372K	Sell	7,844 -55,260	-88%	-$2.58M	0.03%	200
2025 Q2	$2.92M	Buy	63,104 +4,016	+7%	+$197K	0.26%	94
2025 Q1	$3.6M	Hold	59,088	–	–	0.32%	66
2024 Q4	$3.34M	Buy	59,088 +3,338	+6%	+$187K	0.29%	72
2024 Q3	$3M	Buy	55,750 +38,732	+228%	+$1.82M	0.31%	82
2024 Q2	$707K	Buy	+17,018	New	+$761K	0.09%	129
2023 Q1	–	Sell	-20,156	Closed	-$1.45M	–	141
2022 Q4	$1.45M	Buy	20,156 +156	+0.8%	+$11.8K	0.63%	58
2022 Q3	$1.42M	Sell	20,000 -30,598	-60%	-$2.22M	0.67%	54
2022 Q2	$3.9M	Buy	50,598 +2,483	+5%	+$189K	0.57%	42
2022 Q1	$3.55M	Buy	+48,115	New	+$3.23M	0.47%	56

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LGT Fund Management's BMY Position: Q1 2026 in Review

LGT Fund Management reduced its Bristol-Myers Squibb (BMY) stake by 40% in Q1 2026, selling an estimated $185K and leaving 4,672 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #230.

LGT Fund Management first reported a position in BMY in Q1 2022 and has held it in 12 quarters since. The position peaked at $3.9M in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

LGT Fund Management held 4,672 shares of Bristol-Myers Squibb worth $283K as of Q1 2026.
LGT Fund Management sold 3,172 Bristol-Myers Squibb shares in Q1 2026, an estimated $185K.
Bristol-Myers Squibb made up 0.01% of LGT Fund Management's portfolio in Q1 2026, its #230 holding.
LGT Fund Management first reported a position in Bristol-Myers Squibb in Q1 2022 and has held it in 12 quarters since.
LGT Fund Management's Bristol-Myers Squibb position peaked at $3.9M in Q2 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on LGT Fund Management's 13F filing for Q1 2026, filed 28 Apr 2026.